(Q45759880)

15 December 2017

title

Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study (English)

1 reference

15 December 2017

main subject

liver transplantation

1 reference

1 reference

1 reference

M Krüger

1

1 reference

15 December 2017

H L Tillmann

2

1 reference

15 December 2017

C Trautwein

3

1 reference

15 December 2017

U Bode

4

1 reference

15 December 2017

K Oldhafer

5

1 reference

15 December 2017

H Maschek

6

1 reference

15 December 2017

K H Böker

7

1 reference

15 December 2017

C E Broelsch

8

1 reference

15 December 2017

R Pichlmayr

9

1 reference

15 December 2017

M P Manns

10

1 reference

15 December 2017

publication date

1 July 1996

1 reference

15 December 2017

published in

Liver Transplantation

1 reference

15 December 2017

volume

2

1 reference

15 December 2017

issue

4

1 reference

15 December 2017

page(s)

253-262

1 reference

15 December 2017

Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection

cites work

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Safety of famciclovir in patients with herpes zoster and genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Use of isotopically chiral [4'-13C]penciclovir and 13C NMR to determine the specificity and absolute configuration of penciclovir phosphate esters formed in HSV-1 and HSV-2 infected cells and by HSV-1-encoded thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Clinical relevance of mutations in the precore genome of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Pilot study of ribavirin and interferon-beta for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

The in vitro anti-hepatitis B virus activity of FIAU [1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020402

21 January 2018

Identifiers

DOI

10.1002/LT.500020402

1 reference

15 December 2017

1 reference

15 December 2017